elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37681484-A6D525CE-C44C-4DE9-888C-37D953266B4E
Q37681484-A6D525CE-C44C-4DE9-888C-37D953266B4E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37681484-A6D525CE-C44C-4DE9-888C-37D953266B4E
Top-down therapy for Crohn's disease: rationale and evidence.
P2860
Q37681484-A6D525CE-C44C-4DE9-888C-37D953266B4E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37681484-A6D525CE-C44C-4DE9-888C-37D953266B4E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bb6b89c9cdcb336a07d43dac5f53e96a72b29ab5
P2860
Risks and benefits of infliximab for the treatment of Crohn's disease